[go: up one dir, main page]

UY31704A - Compuesto heterociclico fusionado - Google Patents

Compuesto heterociclico fusionado

Info

Publication number
UY31704A
UY31704A UY0001031704A UY31704A UY31704A UY 31704 A UY31704 A UY 31704A UY 0001031704 A UY0001031704 A UY 0001031704A UY 31704 A UY31704 A UY 31704A UY 31704 A UY31704 A UY 31704A
Authority
UY
Uruguay
Prior art keywords
fused
compound
heterociclic
represented
formula
Prior art date
Application number
UY0001031704A
Other languages
English (en)
Inventor
Ishikawa Tomoyasu
Kawakita Youichi
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of UY31704A publication Critical patent/UY31704A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

La presente invención provee un compuesto heterocíclico fusionado que tiene una acción inhibidora de tirosina quinasa que está representada por la fórmula
UY0001031704A 2008-03-12 2009-03-11 Compuesto heterociclico fusionado UY31704A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008063363 2008-03-12

Publications (1)

Publication Number Publication Date
UY31704A true UY31704A (es) 2009-11-10

Family

ID=41063727

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001031704A UY31704A (es) 2008-03-12 2009-03-11 Compuesto heterociclico fusionado

Country Status (8)

Country Link
US (1) US20090233937A1 (es)
EP (1) EP2253633A4 (es)
JP (1) JPWO2009113560A1 (es)
AR (1) AR070874A1 (es)
PE (1) PE20091580A1 (es)
TW (1) TW200944528A (es)
UY (1) UY31704A (es)
WO (1) WO2009113560A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2389731C2 (ru) * 2004-06-02 2010-05-20 Такеда Фармасьютикал Компани Лимитед Конденсированное гетероциклическое соединение
WO2011040212A1 (en) 2009-10-01 2011-04-07 Takeda Pharmaceutical Company Limited Therapeutic agent for brain tumor
HUE024504T2 (en) 2010-12-23 2016-01-28 Sanofi Sa Pyrimidine derivatives, a process for their preparation and their use in medicine
KR20130015400A (ko) 2011-08-03 2013-02-14 삼성디스플레이 주식회사 헤테로고리 화합물 및 이를 포함하는 유기 전계 발광 소자
KR101930848B1 (ko) 2011-08-11 2018-12-20 삼성디스플레이 주식회사 헤테로고리 화합물 및 이를 포함하는 유기 전계 발광 소자
KR101971198B1 (ko) 2011-10-19 2019-04-23 삼성디스플레이 주식회사 헤테로시클릭 화합물, 이를 포함하는 유기 발광 소자 및 평판 표시 장치
RU2712220C2 (ru) * 2013-07-31 2020-01-27 Мерк Патент Гмбх Пиридины, пиримидины и пиразины в качестве ингибиторов тирозинкиназы брутона и их применение

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL112249A (en) * 1994-01-25 2001-11-25 Warner Lambert Co Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
JP3290666B2 (ja) 1995-06-07 2002-06-10 ファイザー・インコーポレーテッド 複素環式の縮合環ピリミジン誘導体
US6395733B1 (en) * 1995-06-07 2002-05-28 Pfizer Inc Heterocyclic ring-fused pyrimidine derivatives
AR004010A1 (es) 1995-10-11 1998-09-30 Glaxo Group Ltd Compuestos heterociclicos
DE69718472T2 (de) 1996-07-13 2003-11-06 Glaxo Group Ltd., Greenford Bicyclische heteroaromatische verbindungen als protein tyrosine kinase inhibitoren
AU3461797A (en) 1996-07-19 1998-02-10 Takeda Chemical Industries Ltd. Fas ligand-like protein, its production and use
BR9713552A (pt) 1996-11-27 2000-01-25 Pfizer Derivados de pirimidina bicìclicos condensados
UA71945C2 (en) * 1999-01-27 2005-01-17 Pfizer Prod Inc Substituted bicyclic derivatives being used as anticancer agents
PE20011178A1 (es) 2000-04-07 2001-11-19 Takeda Chemical Industries Ltd Compuestos heterociclicos y su produccion
WO2001098277A2 (en) 2000-06-22 2001-12-27 Pfizer Products Inc. Substituted bicyclic derivatives for the treatment of abnormal cell growth
AU7307101A (en) 2000-06-30 2002-01-14 Glaxo Group Ltd Quinazoline ditosylate salt compounds
WO2003031442A1 (en) 2001-10-05 2003-04-17 Takeda Chemical Industries, Ltd. Heterocyclic compounds, oxazole derivatives, process for preparation of the same and use thereof
HRP20040530A2 (en) 2001-12-12 2004-10-31 Pfizer Prod Inc Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer
BR0214499A (pt) 2001-12-12 2005-05-10 Pfizer Prod Inc Derivados de quinazolina para o tratamento do crescimento anormal das células
US20050009845A1 (en) 2001-12-19 2005-01-13 Caferro Thomas R. Thienopyrimidine compounds as protein tyrosine kinase inhibitors
RU2389731C2 (ru) * 2004-06-02 2010-05-20 Такеда Фармасьютикал Компани Лимитед Конденсированное гетероциклическое соединение
TW200730527A (en) * 2005-12-02 2007-08-16 Takeda Pharmaceuticals Co Fused heterocyclic compound
JP4504337B2 (ja) 2006-09-04 2010-07-14 株式会社御池鐵工所 ガス化炉及びガス化炉システム
RU2009126576A (ru) * 2006-12-12 2011-01-20 Такеда Фармасьютикал Компани Лимитед (Jp) Конденсированное гетероциклическое соединение

Also Published As

Publication number Publication date
WO2009113560A1 (ja) 2009-09-17
EP2253633A4 (en) 2012-02-29
JPWO2009113560A1 (ja) 2011-07-21
EP2253633A1 (en) 2010-11-24
TW200944528A (en) 2009-11-01
PE20091580A1 (es) 2009-11-05
US20090233937A1 (en) 2009-09-17
AR070874A1 (es) 2010-05-12

Similar Documents

Publication Publication Date Title
CY1119218T1 (el) Αναστολεις διυδροπυριδοφθαλαζινονης της πολυμερασης της πολυαδενοσφωσφορικης ριβοζης (parp)
MX366942B (es) Compuesto heterociclico fusionado y su uso para el control de plagas.
MA32938B1 (fr) Composes organiques
CY1112102T1 (el) Υποκατεστημενες πυριμιδοδιαζεπινες χρησιμες ως αναστολεις plk1
EP2376425A4 (en) KINASE INHIBITORS COMPOUNDS
CR20140229A (es) Nuevos derivados bicíclicos de dihidroisoquinolin-1-ona
DK2364308T3 (da) Pyrazinforbindelser som inhibitorer af Phosphodiesterase 10
UA107796C2 (en) Tetracyclic compound
BRPI1010795A2 (pt) compostos antivirais
CY1109911T1 (el) Πυρρολοβενζοδιαζεπινες
EP2120578A4 (en) KINASE INHIBITORS COMPOUNDS
DK3354650T3 (da) Forbindelser der er nyttige som inhibitorer af ATR-kinase
MA32877B1 (fr) Composes organiques
ATE479673T1 (de) Hemmer der neubildung menschlicher immundefekt- viren
CR20120333A (es) Isoquinolinonas y quinazolinonas substituidas.
CR20110169A (es) Compuestos de pirrol
CR20120295A (es) Triazolopiridinas
EP2079727A4 (en) KINASE INHIBITOR COMPOUNDS
EA200900945A1 (ru) Новый способ синтеза агомелатина
CR20110432A (es) Pirimidinas fusionadas
EA201070182A1 (ru) Алкилсульфонилзамещённые тиазолидные соединения
CR20140468A (es) Inhibidores de diacilglicerol aciltransferasa 2
ATE400567T1 (de) Kinaseinhibitoren
UY31704A (es) Compuesto heterociclico fusionado
EA200900946A1 (ru) Новый способ синтеза агомелатина

Legal Events

Date Code Title Description
104 Application deemed to be withdrawn (no substantive examination fee paid)

Effective date: 20100604